…[Any portfolio manager contemplating investing in the fledgling cannabis industry needs] a simple, yet robust, credit model [that ranks] the top 25 public U.S. cannabis companies [to make an informed decision as to which cannabis company/companies) warrants investing their clients’ money in] and this article provides just that].[The model I have created (see below)] is customizable and incorporates data from financial statements (Q3:2019) and market pricing (1/16/20) as well as optional user inputs on qualitative factors like management quality, regulatory environments, business sector risk, and competition. @”Cannabis Central”
The model produces the following ranking:
Editor’s Note: The above excerpts from the original article by Frank Colombo have been edited ([ ]) and abridged (…) for the sake of clarity and brevity. The author’s views and conclusions are unaltered and no personal comments have been included to maintain the integrity of the original article. Furthermore, the views, conclusions and any recommendations offered in this article are not to be construed as an endorsement of such by the editor. Also note that this complete paragraph must be included in any re-posting to avoid copyright infringement.
About the author:
Frank Colombo is Partner and Chief Risk Officer of Aspen Finance LLC, a fund established to lend to and invest in the cannabis industry.
Frank is a seasoned executive with over 20 years of success in consulting, credit research, valuation, and financial planning and analysis.
He was formerly Global Head of High Yield Research at UBS and Managing Director/Head of Research at Seaport Group LLC.
He holds a BA summa cum laude from University of Colorado, an MBA from Stanford University, and a CFA.
NOTE: Frank is available for strategy, financial analysis and valuation consulting and can be reached by emailing firstname.lastname@example.org.